• Craft Beer sees a rise in the US

    Craft Beer sees a rise in the US

    Economia

    Freedom of Choice: As the world's two largest brewers merged into a multinational conglomerate two and a half times the size of the US beer market, the BA was at the center of the discussion, advocating for fair competition for the nation's small and independent craft brewers and access to market ensuring beer enthusiasts get to continue to choose from a vast variety of options.
  • Savills (LON:SVS) Broker Price Targets

    Economia

    Universe Group had its "Corporate" rating reiterated by analysts at FinnCap. They have a GBP 1160.00p price target on the stock. 16/03/2016 - Savills had its "Outperform" rating reiterated by analysts at Credit Suisse. 12/09/2016 - Experian had its "Neutral" rating reiterated by analysts at Exane BNP Paribas. They now have a GBP 495.00p price target on the stock. 22/08/2016 - Experian had its "Neutral" rating reiterated by analysts at Exane BNP Paribas.
  • PNC Financial Services Group Inc. Cuts Position in Xerox Corp. (XRX)

    Economia

    Xerox Corporation (NYSE:XRX) shares now have a mean rating of 2.90 while 3 analysts have recommended the shares as "BUY", 1 commented as "OUTPERFORM" and 7 commented as "HOLD". The Return on Equity (ROE) value stands at 6.7%. The stock has earnings growth of 111.00% yoy and showed a low EPS growth of -19.10% over the past five years.
  • ObamaCare's Death Panel: Trump's HHS Pick Could Undo ObamaCare

    Economia

    Lawmakers have commended Trump's selection of Price. Price and Verma are two of about 70 people who Trump has met so far as he looks to shape his White House and Cabinet team. "We're all in favour of increasing funding for cancer research", Price told STAT News in January. ObamaCare , as it was designed, is totally dysfunctional and has delivered on none of its major promises made by congressional Democrats and President Obama.
  • Andrea Dovizioso:

    Andrea Dovizioso: "Andrea Iannone ei suoi non hanno rispetto"

    Economia

    Dovizioso "vede" la Ducati protagonista. Al momento il paddock della MotoGP si gode le meritate vacanze ma i primi cambiamenti in vista della prossima annata non mancano. Ricordiamo cosa accadde: siamo al penultimo giro e le due Ducati , dopo aver passato in tromba un Rossi in difficoltà, sono in lotta per il secondo gradino del podio; alla staccata della penultima curva, Iannone prova un attacco un pò ottimistico, speronando il compagno di squadra e gettando al vento un gran risultato.
  • Senato vota fiducia finale a legge Bilancio

    Senato vota fiducia finale a legge Bilancio

    Economia

    Legge di Bilancio, ultime news. Il ministro per i rapporti con il parlamento Maria Elena Boschi in Aula al Senato ha posto la questione di fiducia alla manovra di Bilancio. Nella tarda serata di ieri la Commissione Bilancio ha concluso ieri i lavori senza conferire il mandato al relatore. Il Pd non vuole perdere tempo e chiede che la manovra venga approvata nel più breve tempo possibile, per permettere così a Renzi di dare le dimissioni e aprire ufficialmente la crisi di governo, dopo il ...
  • Oil prices hit three-week high amid hopes of Opec production deal

    Oil prices hit three-week high amid hopes of Opec production deal

    Economia

    OPEC and Russian Federation are meeting on November 30 hoping to sign a deal on a coordinated production cut which is supposed to rebalance the oversupplied oil market. The group's own estimates show production at 33.6 million barrels a day last month. The group's level of production in October was 33.8m bpd, meaning it will need to cut production by over 1m bpd if it opts for the lower end of the indicated range.
  • Eli Lilly's Alzhimer's drug fails final clinical trial

    Eli Lilly's Alzhimer's drug fails final clinical trial

    Economia

    It hasn't decided what the next steps for the drug are. Lechleiter said in the statement that the company will "evaluate the impact of these results on the development plans for solanezumab and our other Alzheimer's pipeline assets". Still, it's a stinging setback for Lilly, which has spent more than $3 billion over the past 27 years trying to find a treatment for a disease that is the sixth-leading cause of death in the United States.
  • The Deutsche Bank AG Initiates Coverage on Exelixis Inc. (EXEL)

    Economia

    The company has got a 52-week exceptional price of $18.29 and reached a 52-week lowest of the share price at $3.55. They now have a United States dollars 11 price target on the stock. Deutsche Bank analysts provided their view on Exelixis, Inc . The firm set a "buy" rating and a $17.00 price target on the biotechnology company's stock.